Daxxify fda approval date?

What was the FDA approval date for Daxxify?

Daxxify (daxibotulinumtoxinA-lanm) received FDA approval on February 21, 2022. [1]

When did Daxxify approval happen relative to other botulinum toxin products?

Daxxify’s approval in 2022 came after earlier FDA approvals for other botulinum toxin products (with different formulations and indications), but it is one of the newer options in the class for aesthetic use. [1]

What is Daxxify approved for?

Daxxify is FDA-approved for the temporary improvement in the appearance of moderate to severe glabellar lines (the area between the eyebrows) in adults. [1]

Sources

[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215874